Ikena Oncology Inc (IKNA)
1.69
-0.02
(-1.17%)
USD |
NASDAQ |
Nov 15, 16:00
1.68
-0.01
(-0.59%)
After-Hours: 20:00
Ikena Oncology Total Liabilities (Quarterly): 14.76M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 14.76M |
| June 30, 2024 | 14.63M |
| March 31, 2024 | 17.44M |
| December 31, 2023 | 22.34M |
| September 30, 2023 | 59.99M |
| June 30, 2023 | 15.06M |
| March 31, 2023 | 17.38M |
| December 31, 2022 | 25.29M |
| Date | Value |
|---|---|
| September 30, 2022 | 31.68M |
| June 30, 2022 | 36.82M |
| March 31, 2022 | 34.79M |
| December 31, 2021 | 40.00M |
| September 30, 2021 | 58.44M |
| June 30, 2021 | 62.57M |
| March 31, 2021 | 66.02M |
| December 31, 2020 | 269.45M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
14.63M
Minimum
Jun 2024
269.45M
Maximum
Dec 2020
49.17M
Average
33.24M
Median
Total Liabilities (Quarterly) Benchmarks
| MediciNova Inc | 2.999M |
| NovaBay Pharmaceuticals Inc | 2.805M |
| Palatin Technologies Inc | 10.85M |
| iBio Inc | 7.41M |
| Theriva Biologics Inc | 14.74M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 148.99M |
| Shareholders Equity (Quarterly) | 134.23M |